We hereby describe the satisfactory evolution of rituximab treatment in two patients with Wegener's granulomatosis (WG). Rituximab was indicated for refractoriness to standard treatment in one case and life-threatening myelotoxicity due to alkylating agents in the other. A brief review of previous experience with the use of rituximab in the treatment of WG is presented. © Oristrell et al.; Licensee Bentham Open.
- Rescue treatment
- Wegener's granulomatosis
Oristrell, J., Bejarano, G., Jordana, R., Monteagudo, M., Marí, B., Casanovas, A., & Tolosa, C. (2009). Effectiveness of rituximab in severe Wegener's granulomatosis: Report of two cases and review of the literature. Open Respiratory Medicine Journal, 3, 94-99. https://doi.org/10.2174/1874306400903010094